Earnings Season Sees Investors Sour on 'Omics Tools, MDx Firms | GenomeWeb

NEW YORK (GenomeWeb News) – As second-quarter financial reports continue to roll in, investors have been unimpressed with the results offered by many of the 'omics tools and molecular diagnostics firms that comprise the GenomeWeb Daily News Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.